Poor growth of human adenovirus-12 compared to adenovirus-2 correlates with a failure to impair PKR activation during the late phase of infection  by Wu, Chengjun et al.
Poor growth of human adenovirus-12 compared to adenovirus-2
correlates with a failure to impair PKR activation during the late phase
of infection
Chengjun Wu a, Lufeng Bai a, Zhiqun Li b, Charles E. Samuel b, Göran Akusjärvi a,
Catharina Svensson a,n
a Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden
b Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA, USA
a r t i c l e i n f o
Article history:
Received 14 September 2014
Returned to author for revisions
15 October 2014
Accepted 11 November 2014
Available online 29 November 2014
Keywords:
Adenovirus
VA RNA
IFN
PKR
eIF2α
a b s t r a c t
Human adenovirus type 12 (HAdV-12) displays a relatively low virulence and slow replication in
cultured human cells, which is manifested by premature death of HAdV-12-infected cells. Whereas
HAdV-2 induction of IFN-β expression was transient, HAdV-12-infected cells maintained high levels of
IFN-β expression, protein kinase R (PKR) activation and eIF-2α phosphorylation throughout the
infectious cycle. The importance of the IFN-inducible PKR kinase in restriction of HAdV-12 was
supported by the enhanced growth of the virus following PKR knockdown in HeLa cells. Ectopic
expression of HAdV-2 VA RNAI increased HAdV-12 hexon protein expression, suggesting that insufﬁcient
VA RNA expression contributes to the restricted growth of HAdV-12. Although some adenovirus species
are known to persist in human lymphoid tissues, HAdV12 has so far not been found. Thus, it is possible
that the inability of HAdV12 to evade the INF response may have implications for the virus to establish
long-lasting or persistent infections.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human adenoviruses (HAdVs) have been implicated in a wide
range of human illnesses, including respiratory disease, gastro-
enteritis, pharyngitis, keratoconjunctivitis, meningoencephalitis,
acute hemorrhagic cystitis, and hepatitis (Fields et al., 2013). More
than 60 types of HAdV, divided into eight species designated as A,
B1, B2, C, D, E, F and G (http://hadvwg.gmu.edu), have been
identiﬁed. Here we have analyzed the human adenovirus type 12
(HAdV-12), which belongs to the highly oncogenic species A, to
understand why this virus has a much lower virulence and causes
slower infections in human tissue culture cells (Scheidtmann et al.,
1975) compared to the non-oncogenic HAdV-2. Whereas the
oncogenic potential of HAdV-12 in rodents is high and dependent
on the viral oncogenes E1A and E1B, the reason(s) for the lower
virulence remains to be explained.
Early recognition of HAdV infection by the innate immune
system generates an antiviral response that is biased toward the
type I interferon (IFN) pathway (Fejer et al., 2008; Nociari et al.,
2007; Zhu et al., 2007). The classical antiviral IFN response is
initiated by cellular sensors of pathogen-associated molecular
patterns that lead to activation of transcription factors of which
interferon regulatory factor 3 (IRF3) is centrally important (Hiscott,
2007; Panne et al., 2007). Activated IRF3 in combinationwith NF-κB
and AP1 binds to the beta interferon (IFN-β) promoter, leading to
expression of the IFN-β mRNA, as well as transcription of other
IRF3-dependent genes (Nociari et al., 2009; Panne et al., 2007).
Activation of IRF3 requires phosphorylation, dimerization and
subsequent nuclear localization of the factor. This cytoplasmic
signaling cascade is initiated by cellular sensors that typically are
virus-derived double-stranded RNA (dsRNA). HAdVs encode for one
or two short RNA polymerase III products, called the virus asso-
ciated RNAs (VA RNAs) (Mathews and Shenk, 1991; Punga et al.,
2013) that are approximately 160 nucleotides long and display a
highly double stranded nature. The VA RNAs induce IFN-β produc-
tion, and the subsequent expression of IFN-stimulated genes, (ISGs)
(Weber et al., 2006; Yamaguchi et al., 2010) is primarily through the
RIG-I-mediated pathway, which recognizes the tri-phosphorylated
status of the 50-end of the VA RNAs (Minamitani et al., 2011).
Depending on the host cell, additional cellular factors contribute to
IFN-β induction via viral DNA sensing cascades (Lam et al., 2014;
Stein and Falck-Pedersen, 2012).
Although the VA RNAs appear to be an important player in the
early induction of IFN-β expression, a major function of VA RNAI of
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HAdV-5 is to enable the virus to evade cellular restriction of viral
growth and maintain the translational capacity in the infected cell
(Thimmappaya et al., 1982). As a member of the family of ISGs, the
serine/threonine protein kinase R (PKR) plays a key role in the
establishment of the antiviral state by controlling the activity of the
alpha subunit of eukaryotic initiation factor 2 (eIF2α) (Farrell et al.,
1977; Samuel, 1993). Activation of PKR occurs by dimerization and
autophosphorylation of two PKR molecules binding to the same
dsRNA. Activated PKR phosphorylates eIF2α, which results in a failure
of ribosome assembly on the mRNA. In HAdV-5-infected cells a PKR
monomer binds to the apical stem/central domain of VA RNAI
(Launer-Felty and Cole, 2014; Mellits et al., 1990). VA RNAI is produced
in enormous quantities during HAdV-5 infection and leads to an
antagonism of PKR activation (Mathews and Shenk, 1991; Punga et al.,
2013). Although the majority of HAdVs have two VA RNA species,
HAdV-12 encodes only one VA RNA that is largely homologous to the
HAdV-2/5 VA RNAI (reviewed in Ma and Mathews (1996).
Our previous results revealed that HAdV-12 infection in human
primary lung ﬁbroblast, IMR-90 cells, is characterized by a slow
progression of the lytic infection, a reduced cytopathic effect and a
lower virus yield compared to the non-oncogenic HAdV-2 (Zhao
et al., 2009). By a cDNA microarray analysis we showed that
several ISGs were up-regulated during the late phase of a HAdV-12
infection. We also observed similar effects in HAdV-12 infected
HeLa cells (Dorn et al., 2005). In this report we show that also in
HAdV-12 infected A549 cells IFN-β induction was maintained
throughout the infectious cycle. Both PKR and eIF2α were highly
phosphorylated in HAdV-12 infected cells at times when late viral
protein accumulation declined. In agreement with this observa-
tion, PKR knockdown experiments demonstrated that HAdV-12
was highly sensitive to PKR-mediated growth restriction. The
inability of HAdV-12 to block the translational inhibition evoked by
PKR correlated with an approximately 10,000-fold reduced accumu-
lation of HAdV-12 VA RNA compared to HAdV-2 VA RNAI in A549
cells. Finally, we showed that overexpression of HAdV-2 VA RNAI in
HAdV-12 infected cells rescued the translational capacity and
increased the level of late structural protein accumulation by about
9-fold. Taken together, our results suggest that the poor growth and
restricted virulence of HAdV-12 to a large extent are due to the low
expression of HAdV-12 VA RNA and the subsequent inability to
overcome PKR-mediated growth restriction.
Results and discussion
The poor growth of HAdV-12 correlates with premature cell death and
restricted viral gene expression
The human A549 cell line is permissive for growth of many
HAdVs. However, when compared to the highly efﬁcient propaga-
tion of HAdV-2, HAdV-12 is characterized by slow progression of
the virus life cycle and a low virus yield. A microscopic analysis of
A549 cells infected with 10 FFU/cell of HAdV-2 showed a clear CPE
that gradually increased with time and at 60 h p.i. most cells
displayed a rounded shape and limited attachment to the plastic
surface (Fig. 1A). Despite these signiﬁcant changes in cell morphol-
ogy, the integrity of HAdV-2 infected cells was intact as illustrated
by the almost complete exclusion of trypan blue staining (Fig. 1B).
In contrast, HAdV-12 infection failed to induce a typical CPE but
instead caused changes resembling dying cells, i.e. smaller size and
eventually complete disruption of the cellular integrity (Fig. 1A).
Further, cell death induced by HAdV-12 was veriﬁed by staining of
more than 60% of the cells with trypan blue at 60 h p.i. (Fig. 1B).
To determine how the metabolic activity was affected by the
observed changes in cell morphology, viral RNA and protein synth-
esis were analyzed at different time points of virus infection in A549
cells. RNA expressionwas quantitated by RT-PCR. In HAdV-2 infected
cells, E1A mRNA expression was detectable at all time points and
continued to accumulate throughout the infectious cycle, whereas
E1A mRNA of HAdV-12 showed a delayed and signiﬁcantly lower
expression, with a maximal expression at 48 h p.i. (Fig. 2A, and
quantitated in Fig. 2B). A similar pattern was observed for the late
gene L3 where HAdV-12 L3 mRNAs started to decline after a peak at
36 h p.i. (Fig. 2A, and quantitated in Fig. 2B). Consistent with this
observation, a Western-blot analysis of late structural protein
accumulation showed that the HAdV-2 capsid proteins continued
to accumulate throughout the infectious cycle whereas the steady-
state level of structural proteins in HAdV-12 infected cells was
signiﬁcantly reduced and declined after a peak at 48 h p.i. (Fig. 2C,
and quantitated in Fig. 2D). Collectively, our results show that HAdV-
12 infection of A459 cells is characterized by a delayed onset of viral
gene expression and a premature cell death, together precluding the
robust production of capsid proteins required for maximal progeny
virion formation.
Although the E1A proteins of HAdV-2 and HAdV-12 are to a great
extent equivalent and essential for activation of other viral genes,
detailed analyses show signiﬁcant differences in functional domains
(Avvakumov et al., 2004). This, for example, is manifested in the
observation that the fraction of potential E2F target genes respond-
ing to HAdV-12 infection in HeLa cells is much smaller than what is
seen during a HAdV-2 infection (Dorn et al., 2005; Zhao et al., 2007).
It is thus likely that both dynamics and kinetics in E1A-induced viral
gene expression differ between the two virus types.
The lower virulence of HAdV-12 compared to HAdV-2 correlates with
increased sensitivity to IFN
We have previously shown that HAdV-12 infection of primary
lung epithelial cells (IMR-90) was severely delayed compared to
infection by HAdV-2, and also induced an expression of a set of ISGs
(Zhao et al., 2009). Similarly, ISGs were also induced in HAdV-12
infected HeLa cells although here the consequences for virus
production were less dramatic (Dorn et al., 2005). To analyze
whether type I IFN was involved in the restriction of HAdV-12
growth, we compared the growth kinetics of HAdV-2 and HAdV-12
in Vero cells that are defective in IFN-β expression as a result of a
chromosomal deletion of the IFN-β gene (Park et al., 2006). In the
absence of IFN signaling, HAdV-2 and HAdV-12 demonstrated more
similar growth rates with respect to production of steady-state
levels of late viral proteins (Fig. 3A) and induction of CPE (Fig. 3B)
compared to infection in A549 cells (Figs. 1A and 2C). To analyze the
impact of ISG expression on late viral protein synthesis we treated
HAdV-2 and HAdV-12 infected Vero cells with IFN-α from 8, 18 or
24 h p.i. and onwards (Fig. 3C). Extracts were prepared at 60 h p.i.
and late structural protein expression visualized by Western blot-
ting. Addition of IFN-α at the early phase of infection (8 h p.i.)
efﬁciently blocked HAdV-12 structural protein production but only
had a negligible effect on HAdV-2 hexon production. When IFN-α
treatment was initiated at 18 h p.i. HAdV-12 late protein expression
was still efﬁciently suppressed, but when IFN-αwas added after the
late phase had commenced (24 h p.i.) essentially no inhibition of
HAdV-12 late protein synthesis was observed (Fig. 3C). Taken
together these results suggested that a major restriction factor for
HAdV-12 growth in tissue culture cells is the failure of the virus to
suppress the type I IFN response. Moreover, the ﬁndings also
indicated that the sensitivity to the antiviral IFN activity is most
pronounced during the early time points. A possible explanation
might be that the abundant expression of late viral RNAs after onset
of DNA replication efﬁciently competes for the cellular translation
machinery.
We have previously shown that HAdV-12 infection of IMR-90
cells results in an induction of IFN-β expression (Zhao et al., 2009).
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RT-PCR analysis of IFN-β mRNA levels in A549 infected cells showed
that HAdV-2 in addition to HAdV-12 also induced IFN-β transcription
during the early phase of infection (Fig. 4A and quantitated in
Fig. 4B). However, in HAdV-2 infected cells, the induction of IFN-β
mRNA accumulation was weak and reached a peak at 18–24 h p.i.
followed by a decline (Fig. 4B). In contrast, in HAdV-12 infected cells
the IFN-β mRNA induction was 4–5 fold more robust and despite a
decrease from 24 h p.i. and onwards, remained detectable through-
out the entire infection (Fig. 4B).
The reason for the different patterns of IFN induction by HAdV-2
and HAdV-12 is not clear. Activation of IFN-β occurs primarily through
a cascade where sensing of different triggers leads to phosphorylation
Fig. 1. HAdV-12 infected A549 cells fail to demonstrate typical CPE. A549 cells were mock infected, or infected with 10 FFU/cell of HAdV-2 or HAdV-12. (A) The appearance of
CPE was inspected microscopically at indicated times after infection. (B) The percentage of living cells was determined using trypan blue exclusion at the indicated times
after infection. Error bars indicate the SD of three separate experiments.
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and nuclear translocation of IRF3. Double stranded (ds)RNA, produced
by symmetrical transcription of the viral genome during the late phase
of infection (Pettersson and Philipson,1974) is one of the most efﬁcient
activators of IFN-β. The triphosphorylated 50-end of VA RNAs triggers
this cascade by RIG (Minamitani et al., 2011). The viral genome itself
can also act as a trigger through multiple DNA sensors recognizing the
cytosolic viral DNA (Lam et al., 2014; Stein and Falck-Pedersen, 2012).
However, the temporal expression observed in our experiments does
not directly agree with any of these being the responsible activator,
unless the delayed and limited induction of IFN in HAdV-2 infected
cells is the result of an active suppression of IFN-β. In support of the
latter possibility is the observation that E1A of HAdV-2 and HAdV-12
differ in their capacity to bind p300 and as a consequence display a
different capacity to interfere with IRF3-dependent activation of IFN-β
transcription (Ackrill et al., 1991; Kalvakolanu et al., 1991).
Sustained induction of IFN in HAdV-12 infected A549 cells correlates
with increased phosphorylation of PKR and eIF-2α
The induction of IFN leads to activation of the JAK/STAT pathway,
which in turn leads to activation of ISGs. One of these genes, PKR, has
been shown to play a major role as an antiviral protein with a capacity
to restrict HAdV growth (Punga et al., 2013; Samuel, 2001). Although
modest, the observed induction of IFN-β expression (Fig. 4) gave a
transient increase of total PKR in HAdV-2 infected A549 cells, and a
gradual increase in the total amount of PKR following an HAdV-12
infection (Fig. 5A). More importantly, in HAdV-12 infected cells,
phosphorylation of PKR appeared at 36 h p.i., whereas in HAdV-2
infected cells phosphorylated PKR was detectable only at the longest
time after infection that was measured, 60 h p.i. Among the most
important substrate of PKR, with respect to its antiviral activity, is
eIF-2α (Samuel, 2001). We therefore measured the accumulation of
phosphorylated eIF-2α. As shown in Fig. 5B, activation of PKR in
HAdV-12 infected cells simultaneously lead to a signiﬁcant eIF-2α
phosphorylation detectable already at 24 h p.i. In HAdV-2 infected
cells, eIF-2α phosphorylation appeared both less and delayed (Fig. 5C).
Collectively, these results suggest that a failure of HAdV-12 to suppress
PKR activation may be a major reason for the abortive replication of
the virus observed in A549 cells.
To further test this hypothesis, we took advantage of the stable
HeLa PKRkd cell line where PKR expression is knocked down to less
than 2% of the control cell line HeLa PKRkd-con (Fig. 6A) by a short-
hairpin RNA interference strategy (Zhang and Samuel, 2007). To
conﬁrm the reduced PKR expression level, HeLa PKRkd and HeLa
PKRkd-con were infected with HAdV-2 and PKR expression level
was analyzed by Western-blot at 36, 48 and 60 h p.i. (Fig. 6A).
Fig. 2. The progression of infection of HAdV-12 is severely reduced compared to HAdV-2. RNA and proteins were extracted from A549 cells infected with 10 FFU/cell of HAdV-2 or
HAdV-12 at indicated times after infection. (A) RT-PCR analysis of viral early (E1A) and late (L3) mRNA. (B) Relative expression of E1A and L3 mRNA using actin as the internal control.
Error bars indicate the SD of three separate experiments. (C) Western blot analysis of viral capsid protein using antibodies against the whole virus particle. (D) Relative accumulation of
adenovirus capsid proteins using actin as the internal control. Error bars indicate the SD of three separate experiments. (** po0.01, *** po0.001).
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Depletion of PKR expression increased the steady-state level of
viral structural proteins in HAdV-12 infected cells (Fig. 6B), where
as PKR depletion had no signiﬁcant effect on viral late protein
expression in HAdV-2 infected cells (Fig. 6B) as shown by quanti-
ﬁed protein amounts (Fig. 6C). Taken together, these results are
consistent with the hypothesis that activated PKR is primarily
responsible for the suppression of HAdV-12 growth. However, VA
RNAI is known to impair the function of dsRNA binding proteins
and processes in addition to suppression of PKR activation and
subsequent translation inhibition through eIF2 phosphorylation
(Kitajewski et al., 1986; Mathews and Shenk, 1991). For example,
A–I editing activity of the dsRNA adenosine deaminase ADAR1 is
antagonized by VA RNAI (Lei et al., 1998) and VA RNAI suppresses
RNAi by binding and impairing Dicer (Andersson et al., 2005;
Lu and Cullen, 2004). The enhancement of HAdV-12 growth by
knock down of PKR suggests that at least in the case of HAdV-12
the concentration of VA RNAI expressed in HeLa cells is sufﬁciently
above the threshold required to impair the function of all targets
other than PKR. The fact that knock down of PKR did not rescue the
growth of HAdV-5 deleted for VA RNAI expression (Zhang and
Samuel, 2007) suggests that one or more cellular proteins in addition
to PKR are responsible for the restricted HAdV-5 mutant growth.
Conceivably in the case of both HAdV-2 and HAdV-12 sufﬁciently
high functional concentrations of VA RNAI are achieved to suppress
functions other than PKR activation, whereas only with HAdV-2 and
not HAdV-12 is the VA RNAI able to also suppress PKR.
The inability of HAdV-12 to evade the antiviral activity of PKR
correlates with a severely reduced accumulation of HAdV-12 VA RNA
compared to HAdV-2 VA RNAI
Both HAdV-2 and HAdV-5 encode two homologous VA RNA genes,
VA RNAI and VA RNAII. However, whereas VA RNAII is non-essential
for lytic virus growth in tissue culture cells, VA RNAI is expressed in
108 copies/infected cell and is required to maintain an efﬁcient
translation during the late phase of infection (Punga et al., 2013). VA
RNAI sequesters PKR and prevents its activation and as a consequence
ensures a high translational capacity during virus infection. HAdV-12
only encodes for one VA RNA species, which is homologous to HAdV-
2/5 VA RNAI (Ma and Mathews, 1996). It is conceivable that the failure
of HAdV-12 to establish an efﬁcient lytic replication in A549 cells could
be due to insufﬁcient levels of HAdV-12 VA RNA expression. Using an
RT-qPCR approach we found that HAdV-2 VA RNAI accumulated to
high levels in A549 cells reaching a maximum steady-state level at
36 h p.i. (Fig. 7). Accumulation of HAdV-12 VA RNA also reached a
maximum at about 36 h p.i. However, two major differences between
Fig. 3. Reduced progression of HAdV-12 infection in Vero cells following interferon
α treatment. The IFN deﬁcient Vero cells were infected with 10 FFU/cell of HAdV-2
or HAdV-12. (A) At indicated times after infection, the accumulation of viral capsid
protein was detected by Western blot analysis using antibodies against the whole
virus particle. (B) The appearance of CPE was inspected microscopically at 48 h p.i.
(C) Following infection, 0 h, IFN-α was added to the infected Vero cells at 8, 18 or
24 h p.i., or left untreated, dimensionless. Protein extracts were prepared at 60 h p.i.
and accumulation of viral late proteins was detected by Western blot analysis.
Fig. 4. HAdV-12 infection of A549 cells triggers a sustained induction of IFN-ß.
A549 cells were infected with 10 FFU/cell of HAdV-2 or HAdV-12. (A) RT-PCR
analysis IFN-β mRNA at indicated h p.i. (B) Relative expression of IFN-β using actin
as the internal control. Error bars indicate the SD of three separate experiments.
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HAdV-2 and HAdV-12 were apparent; ﬁrst, whereas HAdV-2 VA RNA
accumulated to a maximum of almost 108 molecules per cell, the
maximum produced by HAdV-12 was approximately 104 molecules of
VA RNA per cell (Fig. 7B). Second, at the later time points after
infection, VA RNA expression in HAdV-2 infected cells remained high,
but in HAdV-12-infected cells the expression rapidly decreased.
HAdV-2 VA RNAs can rescue late viral protein synthesis in HAdV-12
infected cells
We have previously shown that complementation of adenovirus
mutants lacking the VA RNAs can be efﬁciently achieved by transfec-
tion of VA RNA expressing plasmids and by measuring the production
of late viral proteins by immunoﬂuorescence (Larsson et al., 1986).
A similar stratagem was therefore used to test whether the poor
expression of viral protein in HAdV-12 infected cells could be rescued
by ectopic overexpression of HAdV-2 VA RNA. Due to a poor transfec-
tion efﬁciency of A549 cells we performed the experiment in IMR-90
cells, where the transfection efﬁciency was over 80% (data
not shown). IMR90 cells were transfected with plasmid pHindB,
expressing the HAdV-2 VA RNAI and VA RNAII genes, or plasmid
pAd12-VA, expressing the HAdV-12 VA RNA. Transfected cells were
Fig. 5. Compared to HAdV-2, HAdV-12 infection of A549 cells results in more rapid
and stronger phosphorylation of PKR and eIF2α Protein from A549 cells infected
with 10 FFU/cell of HAdV-2 or HAdV-12 were extracted at indicated times.
(A) Western blot analysis of total (PKR) and phosphorylated (p-PKR) PKR. The
relative phosphorylation of PKR (p-PKR/PKR) is shown below each lane and is
calculated as mean values from three experiments. (B) Western blot analysis of
phosphorylated eIF2α (p-eIF2α). (C) Relative accumulation of p-eIF2α using actin as
the internal control. Error bars indicate the SD of three separate experiments.
(** po0.01, *** po0.001).
Fig. 6. Accumulation of viral proteins in HAdV-12 infected HeLa cells is enhanced
by knock down of PKR. (A) HeLa PKRkd, (KD) and Hela PKRkd-con (C) were infected
with 10 FFU/cell of HAdV-2. Proteins were extracted at indicated times and PKR
expression was analyzed by Western blot. (B) HeLa PKRkd, (KD) and Hela PKRkd-con
(C) were infected with 10 FFU/cell of HAdV-2 or HAdV-12. Proteins were extracted
at indicated times and the accumulated viral proteins were analyzed by Western
blot. (C) Relative accumulation of viral capsid protein using actin as the internal
control. Error bars indicate the SD of three separate experiments.
(* po0.05, ** po0.01, *** po0.001).
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infected with HAdV-12 at 24 h post-transfection. At 48 h p.i. the cells
were ﬁxed and stained with a monoclonal antibody detecting the
hexon protein. In IMR90 cells, the infection is slower than that in A549
cells and by 24 h p.i. the synthesis of late viral proteins has just started
(Zhao et al., 2009). As shown in Fig. 8, pHindB cotransfection resulted
in a 9-fold improvement of HAdV-12 hexon expression compared to
mock-transfected IMR-90 cells. pAd12-VA cotransfection enhanced
late protein synthesis less than 4-fold. In both cotransfection experi-
ments, about 5–10 times more ectopically expressed VA RNA was
obtained compared to levels expressed from the infected HAdV-12
genome (data not shown). Taken together, we conclude that the
reduced translation of late proteins in HAdV-12 infected cells is due to
insufﬁcient amounts of VA RNA and that overexpression of either
HAdV-2 VA RNA or HAdV-12 VA RNA can rescue the defect.
Conclusion
Herein we establish that an important contributing factor
responsible for the slow and inefﬁcient growth of HAdV-12 in
A549 cells appears to be the failure of the HAdV-12 VA RNA to
efﬁciently mount a suppressive effect on PKR activation. The
failure to block PKR activation results in a prolonged phosphoryla-
tion of eIF2α, a low translational efﬁciency of late viral structural
protein and a premature death of the infected cells. Although this
has yet only been analyzed in infected tissue culture cells, the
inability of HAdV12 to evade the INF response of the host may
have implications for the virus to establish long-lasting or persis-
tent infections in humans.
Materials and methods
Cell lines and virus
A549 (Human lung adenocarcinoma epithelial cells), IMR-90
(human lung ﬁbroblasts), HeLa, and Vero cells (African green
monkey kidney cell) were maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine
serum (FBS). HeLa PKRkd and HeLa PKRkd-con (Zhang and Samuel,
2007) were maintained in DMEM containing 10% FBS and supple-
mented with 1 μg/ml puromycin (Sigma). HAdV-2 and HAdV-12
were ampliﬁed in HeLa cells and puriﬁed by cesium chloride
density gradient centrifugation. Virus titers were measured as
ﬂuorescence forming units (FFU) (Philipson, 1961) using a pan-
hexon antibody (MAB8052, Millipore).
Virus infection
Cells were mock-infected or infected in serum-free DMEM with
indicated virus at a ﬁxed multiplicity of 10 FFU/cell. After a 1 h
adsorption period at 37 1C in humidiﬁed air with 5% CO2, the
medium was replaced with DMEM supplemented with 2% FBS
and the infected cells were further incubated at 37 1C with 5% CO2.
The progression of infection was documented using a Leica DMIRB
microscope at indicated time points post infection. At indicated
times cells were harvested by trypsinization and the cell pellets
were snap frozen for further RNA, DNA and/or protein extraction.
Trypan blue exclusion was used to determine the number of viable
cells. Brieﬂy, at the indicated time point, trypan blue was added and
the percentage of living cells was determined by counting both
unstained and stained cells at 40 magniﬁcation and in three
randomly chosen ﬁelds.
RNA preparation and RT-PCR
Collected cells were lysed in IsoB/NP40 (10 mM Tris pH 7.9,
0.15 M NaCl, and 1.5 mM MgCl2) and total cytoplasmic RNA
Fig. 7. Accumulation of VA RNA in HAdV-2 and HAdV-12 infected A549 cells (A) VA
RNA expression in HAdV-2 and HAdV-12 infected A549 cells analyzed by PCR.
(B) Quantiﬁcation of VA RNA accumulation in HAdV-2 and HAdV-12 infected A549
cells by Q-RTPCR. Error bars indicate the SD of three separate experiments.
Fig. 8. Ectopic expression of VA RNA can rescue late viral protein synthesis in HAdV-12 infected cells; IMR90 cells were transfected with plasmids expressing HAdV-2 or
HAdV-12 VA RNA, prior to infection with 10 FFU/cell of HAdV-12. Expression of HAdV-12 hexon protein was analyzed by immunoﬂuorescence at 48 h p.i. and determined by
ImageJ captured intensities. The fold increase in hexon expression was calculated relative to infected, but mock transfected cells.
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isolated by phenol extraction. The expression of E1A, L3 and actin
mRNA was analyzed by reverse transcription followed by a PCR
step (RT-PCR). First, single-stranded cDNA was generated from
2 mg cytoplasmic RNA by SuperScriptTM II Reverse Transcriptase
(Invitrogen) with Oligo (dT)12–18 as primer, according to the
manufacturer's instructions. Ampliﬁcation of DNA was performed
in a thermocycler with 50 ng of cDNA in a total volume of 25 ml.
PCR products were analyzed by electrophoretic separation on a
1.2% agarose gel. The PCR primer sequences used were as follows:
HAdV-2 E1A, 50-GTGCCAGCGAGTAGA-30 and 50-TGGTCCAAAA-
GACTG-30; HAdV-12 E1A, 50-ATGAGAACTGAAATGACTCCC-30 and
50-CATTCACCGCCTGTTCATTAT-30; HAdV-2 L3, 50-GCCTGTGGAC-
TATTC-30 and 50-CGGTAATAAGGTTCA-30; HAdV-12 L3, 50-CAG-
GATGCCTCGGAGTACCTGAG-30 and 50-GGAGCCACGGTGGGGTT-30;
Actin, 50-CTGGGACGACATGGAGAAAA-30 and 50-AAGGAAGGCTG-
GAAGAGTGC-30. The PCR reaction conditions were: 95 1C 5 min,
(95 1C for 20 s, 58 1C for 20 s and 72 1C for 20 s)30 cycles and
72 1C 10 min.
SYBR green qRT-PCR
For quantitative RT-PCR (qRT-PCR), total cellular RNA was iso-
lated using the Trizol reagent (Invitrogen) as described by the
manufacturer. Puriﬁed RNA was treated with DNaseI to remove
residual genomic DNA. The concentration and purity of the RNA
was quantiﬁed by NanoDrop spectrophotometry. A two-step
qRT-PCR protocol was employed as follows: ﬁrst, cDNA was
synthesized from 2 μg of total RNA in a volume of 20 μl using
SuperScript™ II Reverse Transcriptase (Invitrogen); second, ampliﬁ-
cations were carried out in a total volume of 20 μl by using iQ™
SYBR Green Supermix (Bio-Rad) in a Miniopticon Real-Time PCR
System (Bio.Rad, CFB-3120). Cycles conditions were 95 1C 10 min
(95 1C for 15 s, 58 1C for 20 s, and 72 1C for 20 s) times 40. All
samples were analyzed in technical triplicate. Nontemplate and
non-RT controls were runwith every assay. The absolute abundance
of each mRNAwas calculated using a standard curve (Giulietti et al.,
2001).
Protein preparation and Western blotting
The collected cell pellets were lysed on ice for 30 min in 50 mM
Tris–HCl, pH 7.4, containing 150 mM NaCl, 1% deoxycholate, 1%
Tween-20 and a protease inhibitor cocktail (Roche). Lysates were
centrifuged at 12,000 rpm for 10 min at 4 1C, and the supernatants
were collected. 15 μg of protein lysate was mixed with
2 Laemmli sample buffer (62.5 mM Tris–HCl pH 6.8, 25% gly-
cerol, 0.01% BFB and 2% SDS), boiled for 5 min and separated on a
10% SDS-PAGE. Following blotting onto an Immobilon-FL Transfer
Membrane (Millipore), the membranes were probed with the
polyclonal anti-Prage antibody directed against puriﬁed HAdV-2
virions (Prage et al., 1970), β-actin (I-19, sc-1616, Santa Cruz), PKR
(K-17, sc-707, Santa Cruz), p-PKR (Thr451, sc-101784, Santa Cruz),
p-eIF-2α (Ser-52, sc-12412-R Santa Cruz), or a monoclonal anti-
body directed against E1A (sc-430, Santa Cruz).
Data analysis
The density of the bands from digital images of PCR gels and
Western blots were obtained using ImageJ. The obtained density
values were used to calculate the relative density of each band using
actin as the internal control. A minimum of three separate experi-
ments were used to calculate the standard deviation between the
repetitions. The statistical signiﬁcance of the observed difference
between HAdV2 and HAdV12 was determined with unpaired Stu-
dent's t-test using the GraphPad Prism software version 5.01 (Graph-
Pad Software, San Diego, CA).
Complementation of HAdV-12 translation by VA RNA cotransfection
IMR90 cells seeded in 12-well chamber slides were transfected
with 0.5 mg plasmid pHindB, expressing HAdV-2 VA RNAI and
VARNAII (Svensson and Akusjarvi, 1984) or pAd12VA, expressing
HAdV-12 VA RNA. At 24 h post-transfection cells were infected with
HAdV-12 (10 FFU/cell). After an additional 48 h incubation hexon
protein expression was visualized by indirect immunoﬂuorescence
using a pan-hexon antibody (Millipore, MAB8052). In brief, infected
cells were washed three times with PBS, ﬁxed in 95% methanol for
5 min at room temperature, washed 35 min with PBS followed by
a blocking step with 1% BSA for 30 min at room temperature. The
primary pan-hexon antibody (diluted 1ː500) was incubated over-
night at 4 1C. After a 310 min wash with PBS the secondary
antibody (anti-mouse IgG-FITC, F9006, Sigma, diluted 1:400) was
added and incubated for 1 h at room temperature. Finally, the slides
were washed 310 min with PBS and mounted with coverslips.
Images were acquired at 20magniﬁcation using a Nikon Eclipse
90i microscope and the NIS-Elements Ar 3.6 software. The intensity
of the hexon signal was determined using ImageJ and the mean fold
increase from three experiments calculated was compared to mock
transfected cells.
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